Lv1
10 积分 2025-12-04 加入
A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance
4个月前
已完结
From concept to cure: The evolution of CAR-T cell therapy
6个月前
已完结
Fine tuning towards the next generation of engineered T cells
6个月前
已完结
One-step synthesis of various burr-like TiO2 nanostructures: Nanotubes, nanorods, nanotetrapods, nano-urchins
6个月前
已完结
Thiol/disulfide homeostasis as a marker of oxidative stress in rosacea: a controlled spectrophotometric study
6个月前
已完结
Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center
7个月前
已完结
Essentials of Pathology and Dermatopathology Evaluation for Melanocytic Tumors
7个月前
已关闭
Targeting the MAPK pathway for NRAS mutant melanoma: from mechanism to clinic
7个月前
已完结
Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial
7个月前
已完结
Transdermal drugs and delivery strategies: History, advances and future prospects
7个月前
已完结